(Q40528039)

English

Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3.

scientific article published on August 2004

Statements

Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3. (English)
Anasuya Vishvanath
Srinivas Annavarapu
Lynn Moscinski

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit